Summer Road Llc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Summer road llc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Summer Road Llc Today - Breaking & Trending Today

Analysts Set Ocular Therapeutix, Inc. (NASDAQ:OCUL) Price Target at $15.17

Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six brokerages that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average […] ....

United States , Piper Sandler , Tower Research Capital , Essex Investment Management Co , Ameritas Investment Partners Inc , Ocular Therapeutix Inc , Barclays Plc , Ocular Therapeutix , Get Free Report , Marketbeat Ratings , Summer Road Llc , Investment Partners , Research Capital , Essex Investment Management , Investment Management , Get Free , Ocular Therapeutix Daily ,

Ocular Therapeutix (NASDAQ:OCUL) Stock Rating Reaffirmed by JMP Securities

JMP Securities restated their market outperform rating on shares of Ocular Therapeutix (NASDAQ:OCUL – Free Report) in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a $24.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts also recently issued research reports about the stock. HC Wainwright reaffirmed a buy […] ....

United States , Piper Sandler , Rabia Gurses Ozden , Steward Partners Investment Advisory , Ocular Therapeutix Company Profile , Ocular Therapeutix Inc , China Universal Asset Management Co , Securities Exchange Commission , Tower Research Capital , Ocular Therapeutix , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Summer Road Llc , Universal Asset Management , Partners Investment Advisory , Research Capital , Ocular Therapeutix Daily , Nasdaq Ocul , Reiterated Rating , Jmp Securities ,

Ocular Therapeutix (OCUL) Set to Announce Earnings on Monday

Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) is set to release its earnings data after the market closes on Monday, March 11th. Analysts expect Ocular Therapeutix to post earnings of ($0.28) per share for the quarter. Ocular Therapeutix Stock Down 3.8 % Shares of NASDAQ OCUL opened at $9.98 on Friday. The company’s 50-day simple […] ....

United States , Piper Sandler , Rabia Gurses Ozden , Securities Exchange Commission , Hermes Inc , Marshall Wace , Renaissance Technologies , Ocular Therapeutix Inc , Nuveen Asset Management , Vanguard Group Inc , Ocular Therapeutix , Get Free Report , Therapeutix Stock Down , Exchange Commission , Summer Road Llc , Asset Management , Resure Sealant , Ocular Therapeutix Daily ,

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Major Shareholder Purchases $6,999,999.52 in Stock

Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) major shareholder Summer Road Llc purchased 930,851 shares of Ocular Therapeutix stock in a transaction that occurred on Monday, February 26th. The stock was acquired at an average price of $7.52 per share, with a total value of $6,999,999.52. Following the transaction, the insider now owns 8,591,401 […] ....

New York , United States , Piper Sandler , Sg Americas Securities , Rafferty Asset Management , Securities Exchange Commission , Harvest Investment Services , York State Common Retirement Fund , Ocular Therapeutix Inc , Ocular Therapeutix , Get Free Report , Summer Road Llc , Exchange Commission , Investment Services , Asset Management , Montreal Can , Resure Sealant , Ocular Therapeutix Daily ,